Stock Titan

When a fusion energy company and a decarbonization SPAC find each other, the real question is not about the technology. It is about whether public markets can hold long-duration science assets.

A routine earnings disclosure from a $4.6 billion aerospace conglomerate is a reference point, not a headline, and knowing the difference is the job.

A signed acquisition of this size puts $12 to $13 billion in gaming sector debt in motion, and the asset base underneath it is exactly what tokenization platforms are targeting.

In clinical-stage biotech, a leadership swap is rarely just a personnel decision. The compensation terms tell you what the board believes about survival and exit.

Coordinated Form 4 filings at a major NAND flash supplier are a primary-source signal for anyone running AI infrastructure exposure.